Pyridine

Pyridine

SCHEMBL1173490

Cc1ccc(B(c2ccc(C)cc2)c2ccc(C)cc2)cc1.c1ccncc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 2/20 0.41
NAPRT Q6XQN6 1/20 0.41
CA2 P00918 1/20 0.41
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
ORAI1 Q96D31 1/20 0.41
ORAI2 Q96SN7 1/20 0.41
ORAI3 Q9BRQ5 1/20 0.41
TRPV6 Q9H1D0 1/20 0.41
ACHE P22303 2/20 0.38
LMNA P02545 1/20 0.38
ALOX12 P18054 1/20 0.38
RAB9A P51151 5/20 0.34
NPC1 O15118 4/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.33
FLT3 P36888 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Xylene SCHEMBL27431590 0.85 TDP1 (0.56) TDP1TSHRNAPRTACHELMNA
P-Xylene SCHEMBL1700858 0.85 TDP1 (0.56) TDP1TSHRNAPRTACHELMNA
P-Xylene SCHEMBL29229140 0.83 TDP1 (0.53) TDP1TSHRNAPRTACHELMNA
P-Xylene SCHEMBL10614849 0.83 TDP1 (0.53) TDP1TSHRNAPRTACHELMNA
P-Xylene SCHEMBL93217 0.83 TDP1 (0.53) TDP1TSHRNAPRTACHELMNA
P-Xylene SCHEMBL20640077 0.80 TDP1 (0.50) TDP1TSHRNAPRTACHELMNA
SCHEMBL16709340 0.80 ACHE (0.53) TDP1TSHRCA2LPLLIPG
SCHEMBL11957229 0.80 ACHE (0.53) TDP1TSHRCA2LPLLIPG
Pyridine SCHEMBL394177 0.80 TSHR (0.50) TDP1TSHRNAPRTORAI1ORAI2
SCHEMBL13231709 0.80 CA2 (0.58) TDP1TSHRCA2LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436173-B2 Boron compounds, their production processes, and functional electronic devices using same KYOTO UNIVERSITY (JP) 2013-05-07 US disclosed
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME Kyoto University and Nippon Shokubai Co., LTD. 2011-02-24 US disclosed
EP-2233490-A1 NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME Kyoto University (JP) 2010-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME ETFB, SLC40A1, SLC19A1 TDP1 3997/4885TSHR 3575/4885NAPRT 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.